The development of organ transplants—which include kidneys, liver, heart, lungs, and pancreas—has led to the development of immunosuppressant drugs. These drugs are meant to suppress the body's natural reaction to reject the for-

eign protein so the person doesn't reject the transplanted organ. Some of these drugs include azathioprine (Imuran), cyclosporine (Sandimmune), muromonab-DC3 (Orthoclone OKT3), mycophenolate mofetil (Cell Cept), and tacrolimus (FK506 Prograf).

Some of the side effects of these drugs include nausea and vomiting and an increased risk of tumor growth. Significant leukopenia and thrombocytopenia may occur. These drugs are expensive and must be continued for the life of the patient.

0 0

Post a comment